194 related articles for article (PubMed ID: 31805999)
1. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin.
Bae WJ; Ahn JM; Byeon HE; Kim S; Lee D
J Exp Clin Cancer Res; 2019 Dec; 38(1):484. PubMed ID: 31805999
[TBL] [Abstract][Full Text] [Related]
2. Loss of Tyrosine Phosphatase Delta Promotes Gastric Cancer Progression via Signal Transducer and Activator of Transcription 3 Pathways.
Wu L; Gao L; Kong D; Xue H
Dig Dis Sci; 2019 Nov; 64(11):3164-3172. PubMed ID: 31041642
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
[TBL] [Abstract][Full Text] [Related]
4. GAGE7B promotes tumor metastasis and growth via activating the p38δ/pMAPKAPK2/pHSP27 pathway in gastric cancer.
Shi DB; Ma RR; Zhang H; Hou F; Guo XY; Gao P
J Exp Clin Cancer Res; 2019 Mar; 38(1):124. PubMed ID: 30871606
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
[TBL] [Abstract][Full Text] [Related]
6. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
Acun T; Demir K; Oztas E; Arango D; Yakicier MC
OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062
[TBL] [Abstract][Full Text] [Related]
7. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells.
Zheng L; Jiang G; Mei H; Pu J; Dong J; Hou X; Tong Q
BMC Cancer; 2010 Feb; 10():33. PubMed ID: 20137078
[TBL] [Abstract][Full Text] [Related]
8. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation.
Zhang F; Wang B; Qin T; Wang L; Zhang Q; Lu Y; Song B; Yu X; Li L
Mol Cell Biochem; 2020 Oct; 473(1-2):1-13. PubMed ID: 32602014
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
[TBL] [Abstract][Full Text] [Related]
10. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
Ortiz B; Fabius AW; Wu WH; Pedraza A; Brennan CW; Schultz N; Pitter KL; Bromberg JF; Huse JT; Holland EC; Chan TA
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8149-54. PubMed ID: 24843164
[TBL] [Abstract][Full Text] [Related]
11. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
12. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis.
Ortiz B; White JR; Wu WH; Chan TA
Oncotarget; 2014 Aug; 5(16):6976-82. PubMed ID: 25138050
[TBL] [Abstract][Full Text] [Related]
14. Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
Peyser ND; Du Y; Li H; Lui V; Xiao X; Chan TA; Grandis JR
PLoS One; 2015; 10(8):e0135750. PubMed ID: 26267899
[TBL] [Abstract][Full Text] [Related]
15. Increased metastasis with loss of E2F2 in Myc-driven tumors.
Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia.
Song L; Jiang W; Liu W; Ji JH; Shi TF; Zhang J; Xia CQ
Acta Paediatr; 2016 Mar; 105(3):e132-41. PubMed ID: 26607758
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
18. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
[TBL] [Abstract][Full Text] [Related]
19. Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.
Lin SC; Hsiao KY; Chang N; Hou PC; Tsai SJ
J Pathol; 2017 Apr; 241(5):638-648. PubMed ID: 28026024
[TBL] [Abstract][Full Text] [Related]
20. miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma.
Si Y; Zhang H; Ning T; Bai M; Wang Y; Yang H; Wang X; Li J; Ying G; Ba Y
Cell Physiol Biochem; 2017; 42(4):1670-1683. PubMed ID: 28738343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
